Related Experiment Video
Updated: Jun 3, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
[Chronic hepatitis and occult HCV infection]
Arleta Kowala-Piaskowska1, Iwona Mozer-Lisewska, Tram N Q Pham
1Klinika Chorób Zakaźnych i Neurologii Dzieciecej, Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Poznań. arletakp1@wp.pl
Insights
Hepatitis C virus (HCV) can replicate outside the liver, leading to persistent occult infections. This extrahepatic replication impacts immune response and virus persistence, even after treatment.
Area of Science:
- Virology
- Immunology
Context:
- Hepatitis C virus (HCV) discovery in 1989.
- HCV is a positive single-strand RNA virus.
- Chronic Hepatitis C (CHC) affects 48-86% of infected patients, potentially leading to liver failure, cirrhosis, or cancer.
Purpose:
- To highlight the extrahepatic replication of HCV.
- To discuss the implications of persistent occult HCV infections.
- To explore the impact on immune response and virus persistence.
Summary:
- HCV replication is not limited to the liver; it occurs in extrahepatic tissues.
- Occult HCV infections can persist even after successful CHC treatment or spontaneous viral clearance.
- Persistent HCV replication in hepatocytes and lymphoid cells may cause continuous immune stimulation, leading to immune tolerance and impaired responses.
Impact:
- Understanding extrahepatic replication is crucial for managing HCV.
- Occult HCV infections have growing significance in organ transplantation.
- This research sheds light on mechanisms of viral persistence and immune evasion.
Abstract:
Hepatitis C virus (HCV) was discovered in 1989. HCV is a positive single-strand RNA. We all have thought, that HCV can replicate only in liver tissue, but now we know, that HCV can replicate in extrahepatic tissue as well. In about 48-86% of HCV infected patients, chronic hepatitis C (CHC) has been noticed and eventually, after tens of years, liver insufficiency, cirrhosis or hepatocellular carcinoma. The current recommended treatment for CHC is a combination of pegylated-interferon alpha and Ribavirin. Presently it is known, that HCV infection can persist as an occult infection. RNA HCV can be detected in patients after successful treatment for CHC or spontaneous elimination. Persistent HCV replication in hepatocytes or lymphoid cells would likely lead to continuous antigenic stimulation of the immune system. This prolonged replication may contribute to the immune tolerance of HCV, impairment of immune response and even further virus persistence. This occult infection grows more important in transplantation.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology
